Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Vanessa Rodrik-Outmezguine

mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer

Science Translational Medicine

English

Related publications

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

Molecular Cancer Therapeutics

Cancer Research

English

Alpelisib Extends PFS in PIK3CA-Mutant Breast Cancer

Cancer Discovery

English

Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer

Cancer Research

English

Approaching Resistance to Targeted Inhibition of PI3K in Breast Cancer

English

Effective Use of PI3K and MEK Inhibitors to Treat Mutant Kras G12D and PIK3CA H1047R Murine Lung Cancers

Nature Medicine

Molecular Biology

English

FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer

Cancer Research

English

Differential Compensation Mechanisms Define Resistance to PI3K Inhibitors in PIK3CA Amplified HNSCC

Otorhinolaryngology-Head and Neck Surgery

English

Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer

Cancer Discovery

English

Specific Apoptosis Induction by the Dual PI3K/mTor Inhibitor NVP-BEZ235 in HER2 Amplified and PIK3CA Mutant Breast Cancer Cells

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English